101 related articles for article (PubMed ID: 15099948)
1. Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil.
Brenna SM; Silva ID; Zeferino LC; Pereira JS; Martinez EZ; Syrjänen KJ
Gynecol Oncol; 2004 May; 93(2):374-80. PubMed ID: 15099948
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
Li CY; Liu JH; Huang BJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.
Hernádi Z; Szarka K; Sápy T; Krasznai Z; Veress G; Póka R
BJOG; 2003 Feb; 110(2):205-9. PubMed ID: 12618167
[TBL] [Abstract][Full Text] [Related]
5. p53 gene alterations and human papillomavirus type 16 infection in early stages of cervical carcinoma in Serbia.
Malisic E; Jankovic R; Majkic M; Dobricic J; Radulovic S
J BUON; 2008; 13(4):525-32. PubMed ID: 19145674
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 in patients with invasive cervical cancer stages IB to IIB.
Kainz C; Kohlberger P; Gitsch G; Sliutz G; Breitenecker G; Reinthaller A
Gynecol Oncol; 1995 May; 57(2):212-4. PubMed ID: 7729736
[TBL] [Abstract][Full Text] [Related]
7. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
[TBL] [Abstract][Full Text] [Related]
8. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
9. The p53 codon 72 arg/arg homozygous women in central Italy are at increased risk for HPV infections.
Ciotti M; Coletti A; Giuliani L; Cappiello G; Syrjanen K; Favalli C
Anticancer Res; 2006; 26(5B):3745-8. PubMed ID: 17094395
[TBL] [Abstract][Full Text] [Related]
10. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
[TBL] [Abstract][Full Text] [Related]
11. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas.
Andersson S; Rylander E; Strand A; Sällström J; Wilander E
Br J Cancer; 2001 Oct; 85(8):1153-6. PubMed ID: 11710828
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism at codon 72 of p53 is not associated with cervical cancer risk.
Malcolm EK; Baber GB; Boyd JC; Stoler MH
Mod Pathol; 2000 Apr; 13(4):373-8. PubMed ID: 10786802
[TBL] [Abstract][Full Text] [Related]
13. Germline polymorphism of p53 codon 72 in gynecological cancer.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
[TBL] [Abstract][Full Text] [Related]
14. Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India.
Bansal A; Das P; Kannan S; Mahantshetty U; Mulherkar R
Indian J Med Res; 2016 Sep; 144(3):359-365. PubMed ID: 28139534
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].
Suárez-Rincón AE; Morán-Moguel MC; Montoya-Fuentes H; Gallegos-Arreola MP; Sánchez-Corona J
Ginecol Obstet Mex; 2002 Jul; 70():344-8. PubMed ID: 12221910
[TBL] [Abstract][Full Text] [Related]
16. Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.
Høgdall EV; Høgdall CK; Christensen L; Glud E; Blaakaer J; Bock JE; Vuust J; Nørgaard-Pedersen B; Kjaer SK
Anticancer Res; 2002; 22(3):1859-64. PubMed ID: 12168882
[TBL] [Abstract][Full Text] [Related]
17. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
18. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
[TBL] [Abstract][Full Text] [Related]
19. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
[TBL] [Abstract][Full Text] [Related]
20. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.
Tenti P; Vesentini N; Rondo Spaudo M; Zappatore R; Migliora P; Carnevali L; Ranzani GN
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):435-8. PubMed ID: 10794489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
